NCT04940299 2026-03-06Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting35 enrolled
NCT03590054 2024-03-22Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesUniversity of California, San FranciscoPhase 1 Completed35 enrolled